Here's how we restore productivity and vigor to the biomedical research workforce in the midst of COVID-19

MB Omary, M Hassan - Proceedings of the National …, 2020 - National Acad Sciences
MB Omary, M Hassan
Proceedings of the National Academy of Sciences, 2020National Acad Sciences
The first known case of the novel coronavirus (COVID-19) was reported in China in
November 2019; in the United States, the first reported case was on January 22.* Essential
stay-at-home mandates worldwide have helped mitigate the exponential growth in
hospitalizations and death and have led to gradual reopenings in China, South Korea,
several European countries, and parts of the United States. But clearly plenty of danger
remains, as parts of the United States and a handful of other countries experience major …
The first known case of the novel coronavirus (COVID-19) was reported in China in November 2019; in the United States, the first reported case was on January 22.* Essential stay-at-home mandates worldwide have helped mitigate the exponential growth in hospitalizations and death and have led to gradual reopenings in China, South Korea, several European countries, and parts of the United States. But clearly plenty of danger remains, as parts of the United States and a handful of other countries experience major spikes in the number of cases. The pandemic’s public health impact continues to reverberate.
COVID-19 has been a major blow to biomedical research and its workforce. Institutions, including the NIH (Bethesda, MD campus pictured here), can aid biomedical researchers with safe return-to-work programs, appropriate testing for infection, and an infusion of stimulus funds. Image credit: Wikimedia Commons/National Institutes of Health.
National Acad Sciences